Florida International University (FIU) is pursuing commercial partners that are interested in developing and commercializing a technique to detect strains of Pseudomonas Aeruginosa. This common and opportunistic pathogen produces serious infections to patients with low immune system, pneumonia, cystic fibrosis, blood conditions, and to people after surgery. Furthermore, healthy individuals can also develop mild illnesses from these pathogenic strains. These bacteria are associated with severe adverse outcomes if treated with inappropriate initial antibiotic therapy, hence the need of an accelerated technique for accurate and early detection that is noninvasive to the patient.
Several testing methods exist to detect the presence of the Pseudomonas Aeruginosa. However, those techniques are invasive, costly, time consuming, need specialized labs, and highly trained personnel. An innovative technique being investigated at FIU allows for a noninvasive sampling of signature volatiles in the patients’ breath that can potentially provide a fast, accurate and painless medical diagnosis tool. The highlight of this invention is the rapid sampling that can be coupled to commercially available analytical instruments. The samples can be easily collected in the doctor’s office, clinics, and hospitals and coupled to analytical instruments already available in a lab for the comprehensive detection process.
An electronic memory/recording device used to store larger amounts of data in a compact three dimensional space than existing memory technology.
- Noninvasive sampling
- Fast, simple, and produce reliable results
- Requires an inexpensive device that is easily coupled to existing analytical instruments for detection
For additional information about this technology opportunity, please contact Elizabeth Garami at email@example.com or by phone at 305-348-0008 and ask about record IP 1402.